USPTO 2015–2025 USPTO PatentsView Foreign Corporation

ALL India Institute OF Medical Sciences (aiims)

USPTO PatentsView assignee record - 8 granted patents across 12 technology areas, active 2015–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

13.6

Avg claims per patent

-67%

5-year filing velocity

The verdict

ALL holds 8 US patents across 12 technology areas, rank #30,753 of 50,000 tracked assignees.

#30,753
of 50,000 US assignees by volume: Top 62%
by Innovation Score (31.4/100): 13.6
avg claims per patent: -67%
filing velocity, last 5 yrs

Portfolio overview

ALL India Institute OF Medical Sciences (aiims) has been granted 8 US utility patents between 2015 and 2023, placing ALL India Institute OF Medical Sciences (aiims) at rank #30,753 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.6 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, ALL India Institute OF Medical Sciences (aiims) is one of the more focused assignees in the PatentsView dataset. By volume, ALL sits between Alchemica Corporation (8 patents, rank #30,749) and Alpacka RAFT Llc (8 patents, rank #30,757) - the closest US assignees by grant volume. The composite Innovation Score of 31.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 6 in the 2015–2019 window, a -67% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. ALL India Institute OF Medical Sciences (aiims)'s 13.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark ALL India Institute OF Medical Sciences (aiims) against peers pursuing similar technology classes.

Alchemica

8
Alchimer

8
ALG

8
Algoriddim

8
ALL STAR Houseware

8
Alloyed

8
ALP Supply

8
Alpacka RAFT

8
ALL India Institu… ◀

8

What this shows ALL holds 8 patents at rank #30,753, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ALL

By rank, the assignees closest to #30,753 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in ALL's primary technology class.

ALL's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

31 Top 62% higher than 38% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

ALL India Institute OF Medical Sciences (aiims) patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	12.5%
2017	2	25.0%
2018	2	25.0%
2019	1	12.5%
2021	1	12.5%
2023	1	12.5%

Which technologies does ALL India Institute OF Medical Sciences (aiims) patent most?

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 2

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 2

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 2

C07K - PEPTIDES 1

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 1

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1

G21K - TECHNIQUES FOR HANDLING PARTICLES OR IONISING RADIATION NOT OTHERWISE PROVIDED FOR; IRRADIATION DEVICES; GAMMA RAY OR X-RAY MICROSCOPES 1

C09K - MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE 1

G01T - MEASUREMENT OF NUCLEAR OR X-RADIATION 1

A61J - CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 1

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 1

G09B - EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS 1

Top 12 of 12 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#30,753

Across all tracked assignees

Innovation Score

31.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does ALL India Institute OF Medical Sciences (aiims) hold?

ALL India Institute OF Medical Sciences (aiims) holds 8 US granted patents filed between 2015 and 2023, spanning 12 technology areas.

What is ALL India Institute OF Medical Sciences (aiims)'s Innovation Score?

ALL India Institute OF Medical Sciences (aiims) has an Innovation Score of 31.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does ALL India Institute OF Medical Sciences (aiims) focus on?

ALL India Institute OF Medical Sciences (aiims)'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 2 patents. The company has filed patents in 12 CPC subclasses total.

Is ALL India Institute OF Medical Sciences (aiims)'s patent filing rate increasing or decreasing?

ALL India Institute OF Medical Sciences (aiims)'s recent filing velocity is -67% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for ALL India Institute OF Medical Sciences (aiims)'s patents?

ALL India Institute OF Medical Sciences (aiims)'s patents average 13.6 claims each. This falls within the standard range, providing solid legal coverage.

How is the ALL India Institute OF Medical Sciences (aiims) patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

ALL's 8 grants land it in the top 62% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - ALL ranks #30,753 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12N - see who else leads that technology area. C12N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.